Status:
NOT_YET_RECRUITING
Vibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic Medication
Lead Sponsor:
Stanford University
Conditions:
Parkinson Disease, Idiopathic
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to test the efficacy of vibrotactile coordinated reset stimulation to improve movement ability and other symptoms of human subject participants with Parkinsons Di...
Eligibility Criteria
Inclusion
- Age at the time of enrollment: Adults 18 and older
- Idiopathic Parkinson's Symptoms between Hoehn and Yahr stages 2 to 4
- Fluent in English
- Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
- Lives in the United States
Exclusion
- Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies.
- Any current drug or alcohol abuse.
- Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
- Pregnancy, breast-feeding or wanting to become pregnant.
- Patient is unable to communicate properly with staff (i.e., severe speech problems).
- Excessive drooling
Key Trial Info
Start Date :
February 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06583005
Start Date
February 15 2025
End Date
May 15 2027
Last Update
September 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.